Back to search
KRAS G12V Mutant Advanced Epithelial Cancers
Clinical trial pipeline · Data from ClinicalTrials.gov
See which KRAS G12V Mutant Advanced Epithelial Cancers trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which KRAS G12V Mutant Advanced Epithelial Cancers trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This intermediate-size IND will treat participants with incurable, advanced or metastatic cancer, harboring KRAS G12V mutation and appropriate HLA class II matc…
This is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with…